2020/07/25 by Helen Smith · 7 citations
Medicine · Neuroscience · #Artificial Intelligence in Healthcare and Education #Ethics in Clinical Research #Neuroethics, Human Enhancement, Biomedical Innovations
paper · pdf · doi:10.1007/s00146-020-01019-6
openalex publication_date 2020/07/25 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29
Abstract The aim of this literature review was to compose a narrative review supported by a systematic approach to critically identify and examine concerns about accountability and the allocation of responsibility and legal liability as applied to the clinician and the technologist as applied the use of opaque AI-powered systems in clinical decision making. This review questions (a) if it is permissible for a clinician to use an opaque AI system (AIS) in clinical decision making and (b) if a patient was harmed as a result of using a clinician using an AIS’s suggestion, how would responsibility and legal liability be allocated? Literature was systematically searched, retrieved, and reviewed from nine databases, which also included items from three clinical professional regulators, as well as relevant grey literature from governmental and non-governmental organisations. This literature was subjected to inclusion/exclusion criteria; those items found relevant to this review underwent data extraction. This review found that there are multiple concerns about opacity, accountability, responsibility and liability when considering the stakeholders of technologists and clinicians in the creation and use of AIS in clinical decision making. Accountability is challenged when the AIS used is opaque, and allocation of responsibility is somewhat unclear. Legal analysis would help stakeholders to understand their obligations and prepare should an undesirable scenario of patient harm eventuate when AIS were used.